Posting of the DRFP2 Comments for the National Cancer Institute’s (NCI) supporting the NCI Federally Funded Research and Development Center (FFRDC)/Frederick National Laboratory for Cancer Research (FNLCR)
General Information
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: May 13, 2022 03:33 pm EDT
- Original Response Date: May 30, 2022 04:00 pm EDT
- Inactive Policy: 15 days after response date
- Original Inactive Date:
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code:
- NAICS Code:
- Place of Performance:
Description
PURPOSE:
THIS IS A SPECIAL NOTICE. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this Special Notice is to provide responses to questions received in response to the second Draft RFPs released on 4 February 2022. Please find the document entitled “DRFP2 QA Final” attached.
ADDITIONAL INFORMATION:
Additional information concerning the competitive process for the contract will be announced on https://beta.sam.gov/ as well as at the FNLCR Acquisition Portal: https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/. The information posted to Beta SAM takes precedence over information provided elsewhere and serves as the Government’s official government-wide point of entry (GPE).
If you have questions, please email the FNLCR Acquisition Team at: FNLCR_ACQinfo@nih.gov (FNLCR_ACQinfo@nih.gov).
Attachments/Links
Contact Information
Contracting Office Address
- OFFICE OF ACQUISITIONS 31Center Dr. 11A35P
- Bethesda , MD 20892
- USA
Primary Point of Contact
- Lisa Coleman
- licoleman@mail.nih.gov
Secondary Point of Contact
- Lisa Bielen
- lisa.bielen@nih.gov
History
- Jun 14, 2022 11:55 pm EDTSpecial Notice (Original)